Provided by Tiger Trade Technology Pte. Ltd.

Zoetis

77.73
+2.713.61%
Post-market: 77.980.2500+0.32%19:59 EDT
Volume:5.05M
Turnover:391.16M
Market Cap:32.12B
PE:12.73
High:78.59
Open:75.29
Low:75.18
Close:75.02
52wk High:158.30
52wk Low:71.00
Shares:413.22M
Float Shares:412.00M
Volume Ratio:1.05
T/O Rate:1.23%
Dividend:2.06
Dividend Rate:2.65%
EPS(TTM):6.11
EPS(LYR):6.02
ROE:64.91%
ROA:15.35%
PB:10.20
PE(LYR):12.91

Loading ...

Company Profile

Company Name:
Zoetis
Exchange:
NYSE
Establishment Date:
2012
Employees:
14500
Office Location:
10 Sylvan Way,Parsippany,New Jersey,United States
Zip Code:
07054
Fax:
- -
Introduction:
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.

Directors

Name
Position
Kristin C. Peck
Chief Executive Officer and Director
Antoinette R. Leatherberry
Independent Director
Gavin D.K. Hattersley
Independent Director
Gregory Norden
Independent Director
Mark Stetter
Independent Director
Michael B. McCallister
Board Chair and Independent Director
Paul M. Bisaro
Independent Director
Sanjay Khosla
Independent Director
Stephanie Tilenius
Independent Director
Vanessa Broadhurst
Independent Director
Willie M. Reed
Independent Director
Frank A. D'Amelio
Director

Shareholders

Name
Position
Kristin C. Peck
Chief Executive Officer and Director
James Saccaro
Executive Vice President, Chief Financial Officer and Chief Operating Officer
Jamie Brannan
Executive Vice President and Chief Commercial Officer
Jeannette Ferran Astorga
Executive Vice President, Corporate Affairs and Chief Sustainability Officer
Julie Fuller
Chief Human Resources Officer and Executive Vice President,Global Operations
Keith Sarbaugh
Executive Vice President and Chief Digital & Technology Officer
Kevin Esch
Executive Vice President and President, Research and Development
Nick Ashton
Executive Vice President and President, Global Manufacturing and Supply
Rimma Driscoll
Executive Vice President and Head of Global Strategy, Commercial and Business Development and Global BioDevices
Roxanne Lagano
Corporate Secretary and Executive Vice President and General Counsel